SCHEMBL4776560

SCHEMBL4776560

CS(=O)(=O)N(Cc1cccc(Cl)c1Cl)c1ccc(C(C(N)=O)C2CCCO2)cc1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
RECQL P46063 1/20 0.44
ALDH1A1 P00352 2/20 0.40
POLB P06746 1/20 0.40
TSHR P16473 1/20 0.40
MAPK1 P28482 1/20 0.40
MEN1 O00255 1/20 0.38
MAPT P10636 1/20 0.38
KMT2A Q03164 1/20 0.38
SLC6A3 Q01959 8/20 0.37
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
SLC6A2 P23975 3/20 0.36
SLC6A4 P31645 3/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
KCNH2 Q12809 1/20 0.36
GAA P10253 1/20 0.35
PKM P14618 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4774929 0.87 SLC6A4 (0.42) RECQLALDH1A1SLC6A3SLC6A2SLC6A4
SCHEMBL5571822 0.86 ALDH1A1 (0.42) RECQLALDH1A1TSHRMEN1MAPT
SCHEMBL4777308 0.82 SLC6A4 (0.45) ALDH1A1SLC6A3SLC6A2SLC6A4CYP3A4
SCHEMBL4776759 0.81 SLC6A4 (0.44) ALDH1A1SLC6A3SLC6A2SLC6A4CYP3A4
SCHEMBL4777342 0.75 ALDH1A1 (0.38) RECQLALDH1A1MEN1MAPTKMT2A
SCHEMBL4775086 0.75 P2RX7 (0.41) ALDH1A1POLBMAPK1MEN1KMT2A
SCHEMBL4775063 0.74 GAA (0.40) ALDH1A1POLBMEN1MAPTKMT2A
SCHEMBL4776553 0.74 RECQL (0.49) RECQLALDH1A1POLBTSHRMAPK1
SCHEMBL4769594 0.74 GAA (0.48) RECQLALDH1A1POLBMEN1MAPT
SCHEMBL4771366 0.73 GAA (0.39) RECQLALDH1A1POLBMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1942888-A2 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS Cytokinetics, Inc. (US) 2008-07-16 EP claimed
US-20070135435-A1 Certain chemical entities, compositions, and methods CYTOKINETICS, INCORPORATED 2007-06-14 US claimed
WO-2007056078-A2 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS CYTOKINETICS, INC. (US) 2007-05-18 WO claimed
EP-1942888-A2 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS Cytokinetics, Inc. (US) 2008-07-16 EP disclosed
US-20070135435-A1 Certain chemical entities, compositions, and methods CYTOKINETICS, INCORPORATED 2007-06-14 US disclosed
WO-2007056078-A2 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS CYTOKINETICS, INC. (US) 2007-05-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070135435-A1 Certain chemical entities, compositions, and methods KIF5B, KIF2C, PLK1 RECQL 139/4885ALDH1A1 2159/4885POLB 292/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.